Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
The net proceeds will be used for advancing multiple novel small molecule therapeutics focused on GPCR modulators, a proven target class with applications in metabolic disorders, inflammation, immunology, and endocrine diseases.
Lead Product(s): Undisclosed
Therapeutic Area: Nutrition and Weight Loss Product Name: Undisclosed
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Apple Tree Partners
Deal Size: $52.0 million Upfront Cash: Undisclosed
Deal Type: Series A Financing December 14, 2023